Neogen Corporation Cost of Goods Sold (Deprecated 2018-01-31)
Neogen Corporation (NEOG) reported Cost of Goods Sold (Deprecated 2018-01-31) of $40.35 million for the 3-month period ending 2018-02-28, per its 10-Q filed 2018-03-29.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsSold · last filed 2018-03-29
- Neogen Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-02-28 was $40.35M, a 3.96% increase year-over-year.
- Neogen Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-11-30 was $43.35M, a 11.47% increase year-over-year.
- Neogen Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-08-31 was $41.08M, a 15.62% increase year-over-year.
- Neogen Corporation cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-05-31 was $43.33M, a 7.76% increase year-over-year.
- Neogen Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $156.57M, a 13.65% increase from fiscal 2016.
- Neogen Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $137.77M, a 14.45% increase from fiscal 2015.
- Neogen Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $120.38M, a 13.49% increase from fiscal 2014.
- Neogen Corporation cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $106.07M, a 26.20% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-02-28 | $40.35M 10-Q · filed 2018-03-29 | $83.70M derived: sum of 2 quarters · filed 2018-03-29 | $124.78M 10-Q · filed 2018-03-29 | $168.11M derived: sum of 4 quarters · filed 2018-03-29 | ||||
| 2017-11-30 | $43.35M 10-Q · filed 2018-01-05 | $84.43M 10-Q · filed 2018-01-05 | $127.76M derived: sum of 3 quarters · filed 2018-01-05 | $166.58M derived: sum of 4 quarters · filed 2018-03-29 | ||||
| 2017-08-31 | $41.08M 10-Q · filed 2017-09-29 | $84.41M derived: sum of 2 quarters · filed 2017-09-29 | $123.23M derived: sum of 3 quarters · filed 2018-03-29 | $162.12M derived: sum of 4 quarters · filed 2018-03-29 | ||||
| 2017-05-31 | $43.33M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $82.14M derived: sum of 2 quarters · filed 2018-03-29 | $121.03M derived: sum of 3 quarters · filed 2018-03-29 | $156.57M 10-K · filed 2017-07-28 | ||||
| 2017-02-28 | $38.82M 10-Q · filed 2018-03-29 | $77.71M derived: sum of 2 quarters · filed 2018-03-29 | $113.24M 10-Q · filed 2018-03-29 | $153.45M derived: sum of 4 quarters · filed 2018-03-29 | ||||
| 2016-11-30 | $38.89M 10-Q · filed 2018-01-05 | $74.42M 10-Q · filed 2018-01-05 | $114.63M derived: sum of 3 quarters · filed 2018-01-05 | $147.55M derived: sum of 4 quarters · filed 2018-01-05 | ||||
| 2016-08-31 | $35.53M 10-Q · filed 2017-09-29 | $75.74M derived: sum of 2 quarters · filed 2017-09-29 | $108.66M derived: sum of 3 quarters · filed 2017-09-29 | $142.67M derived: sum of 4 quarters · filed 2017-09-29 | ||||
| 2016-05-31 | $40.21M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $73.13M derived: sum of 2 quarters · filed 2017-07-28 | $107.13M derived: sum of 3 quarters · filed 2017-07-28 | $137.77M 10-K · filed 2017-07-28 | ||||
| 2016-02-29 | $32.92M 10-Q · filed 2017-03-31 | $66.93M derived: sum of 2 quarters · filed 2017-03-31 | $97.56M 10-Q · filed 2017-03-31 | $131.82M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-11-30 | $34.01M 10-Q · filed 2016-12-29 | $64.64M 10-Q · filed 2016-12-29 | $98.90M derived: sum of 3 quarters · filed 2017-07-28 | $127.78M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-08-31 | $30.63M 10-Q · filed 2016-09-30 | $64.89M derived: sum of 2 quarters · filed 2017-07-28 | $93.77M derived: sum of 3 quarters · filed 2017-07-28 | $123.03M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2015-05-31 | $34.26M derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $63.14M derived: sum of 2 quarters · filed 2017-07-28 | $92.40M derived: sum of 3 quarters · filed 2017-07-28 | $120.38M 10-K · filed 2017-07-28 | $121.45M 10-K · filed 2015-07-30 | |||
| 2015-02-28 | $28.88M 10-Q · filed 2016-03-31 | $29.13M 10-Q · filed 2015-04-01 | $58.14M derived: sum of 2 quarters · filed 2016-03-31 | $86.11M 10-Q · filed 2016-03-31 | $86.93M 10-Q · filed 2015-04-01 | $115.95M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-11-30 | $29.26M 10-Q · filed 2016-01-08 | $29.51M 10-Q · filed 2014-12-30 | $57.23M 10-Q · filed 2016-01-08 | $57.79M 10-Q · filed 2014-12-30 | $87.07M derived: sum of 3 quarters · filed 2016-07-29 | $114.00M derived: sum of 4 quarters · filed 2016-07-29 | ||
| 2014-08-31 | $27.98M 10-Q · filed 2015-09-30 | $28.28M 10-Q · filed 2014-09-30 | $57.81M derived: sum of 2 quarters · filed 2016-07-29 | $84.74M derived: sum of 3 quarters · filed 2016-07-29 | $110.53M derived: sum of 4 quarters · filed 2016-07-29 | |||
| 2014-05-31 | $29.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $56.77M derived: sum of 2 quarters · filed 2016-07-29 | $82.56M derived: sum of 3 quarters · filed 2016-07-29 | $106.07M 10-K · filed 2016-07-29 | $107.17M 10-K · filed 2014-07-30 | |||
| 2014-02-28 | $26.93M 10-Q · filed 2015-04-01 | $52.73M derived: sum of 2 quarters · filed 2015-04-01 | $76.23M 10-Q · filed 2015-04-01 | $99.22M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-11-30 | $25.79M 10-Q · filed 2014-12-30 | $49.30M 10-Q · filed 2014-12-30 | $72.28M derived: sum of 3 quarters · filed 2015-07-30 | $92.33M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-08-31 | $23.51M 10-Q · filed 2014-09-30 | $46.49M derived: sum of 2 quarters · filed 2015-07-30 | $66.54M derived: sum of 3 quarters · filed 2015-07-30 | $87.24M derived: sum of 4 quarters · filed 2015-07-30 | ||||
| 2013-05-31 | $22.98M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $43.03M derived: sum of 2 quarters · filed 2015-07-30 | $63.73M derived: sum of 3 quarters · filed 2015-07-30 | $84.05M 10-K · filed 2015-07-30 | ||||
| 2013-02-28 | $20.05M 10-Q · filed 2014-04-04 | $23.74M 10-Q · filed 2013-03-28 | $40.74M derived: sum of 2 quarters · filed 2014-04-04 | $61.06M 10-Q · filed 2014-04-04 | $70.41M 10-Q · filed 2013-03-28 | $72.91M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-11-30 | $20.70M 10-Q · filed 2014-01-09 | $23.43M 10-Q · filed 2012-12-28 | $41.02M 10-Q · filed 2014-01-09 | $46.67M 10-Q · filed 2012-12-28 | $52.86M derived: sum of 3 quarters · filed 2014-07-30 | $74.88M derived: sum of 4 quarters · filed 2014-07-30 | ||
| 2012-08-31 | $20.32M 10-Q · filed 2013-09-30 | $23.23M 10-Q · filed 2012-09-28 | $32.17M derived: sum of 2 quarters · filed 2014-07-30 | $54.19M derived: sum of 3 quarters · filed 2014-07-30 | $76.42M derived: sum of 4 quarters · filed 2014-07-30 | |||
| 2012-05-31 | $11.85M derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $33.87M derived: sum of 2 quarters · filed 2014-07-30 | $56.10M derived: sum of 3 quarters · filed 2014-07-30 | $78.82M 10-K · filed 2014-07-30 | $91.62M 10-K · filed 2012-07-30 | |||
| 2012-02-29 | $22.02M 10-Q · filed 2013-03-28 | $44.25M derived: sum of 2 quarters · filed 2013-03-28 | $66.97M 10-Q · filed 2013-03-28 | $76.57M derived: sum of 4 quarters · filed 2013-07-30 | ||||
| 2011-11-30 | $22.23M 10-Q · filed 2012-12-28 | $44.95M 10-Q · filed 2012-12-28 | $54.55M derived: sum of 3 quarters · filed 2013-07-30 | $76.19M derived: sum of 4 quarters · filed 2013-07-30 | ||||
| 2011-08-31 | $22.72M 10-Q · filed 2012-09-28 | $32.31M derived: sum of 2 quarters · filed 2013-07-30 | $53.96M derived: sum of 3 quarters · filed 2013-07-30 | $75.40M derived: sum of 4 quarters · filed 2013-07-30 | ||||
| 2011-05-31 | $9.59M derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $31.24M derived: sum of 2 quarters · filed 2013-07-30 | $52.68M derived: sum of 3 quarters · filed 2013-07-30 | $72.84M 10-K · filed 2013-07-30 | $84.89M 10-K · filed 2012-07-30 | |||
| 2011-02-28 | $21.65M 10-Q · filed 2012-03-30 | $43.09M derived: sum of 2 quarters · filed 2012-03-30 | $63.24M 10-Q · filed 2012-03-30 | |||||
| 2010-11-30 | $21.44M 10-Q · filed 2011-12-30 | $41.60M 10-Q · filed 2011-12-30 | ||||||
| 2010-08-31 | $20.16M 10-Q · filed 2011-09-30 | |||||||
| 2010-05-31 | $67.53M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |